www.achaten-suisse.com

Site search:

Get Xeloda (Capecitabine)

Package	Price	Per pill	Savings	Order
500mg × 10 pills	£146.85	£14.68		Add to cart
500mg × 20 pills	£280.95	£14.05	£12.74	Add to cart
500mg × 30 pills	£376.74	£12.56	£63.80	Add to cart

£ 1.11
Get Premarin
(Conjugated Estrogens 0.625mg)

£ 17.40
Get Synthroid
(Thyroxine 25/50/100/200mcg 100 pills)

£ 6.39
Get Vepesid
(Etoposide 50mg)

£ 1.03
Get Eulexin
(Flutamide 250mg)

£ 0.48
Get Rheumatrex
(Methotrexate 2.5mg)

£ 0.53
Get Cytoxan
(Cyclophosphamide 50mg)

£ 2.97
Get Casodex
(Bicalutamide 50mg)

£ 5.59
Get Arimidex
(Anastrozole 1mg)

£ 1.91
Get Droxia
(Hydroxyurea 500mg)

£ 0.38
Get Nolvadex
(Tamoxifen 10/20mg)

£ 0.83
Get Evista
(Raloxifene 60mg)

Choose Your language:

Testimonials: I recieved the order just fine. They work Great. - Thanks, Larry
Read more »

Capecitabine Industry 2017 : Hengrui Pharmaceutical, Roche, Shandong Qilu, Xeloda Company - Medgadget (blog): Medgadget (blog)Capecitabine Industry 2017 : Hengrui Pharmaceutical, Roche, Shandong Qilu, Xeloda CompanyMedgadget (blog)This is a professional and in-depth study on the current state of the Capecitabine industry
Xeloda Tablet Market Global Briefing 2017 to 2022 - E News Access (press release): E News Access (press release)Xeloda Tablet Market Global Briefing 2017 to 2022E News Access (press release)Global Xeloda Tablet Market Research Report 2017 to 2022 provides a unique tool for evaluating the market, highlighting opportunities, and supporting strategic
2017-2022 Global Xeloda Tablet Market Analysis: Roche, Teva, Mylan, Hikma, Hengrui Medcine - Digital Journal: 2017-2022 Global Xeloda Tablet Market Analysis: Roche, Teva, Mylan, Hikma, Hengrui MedcineDigital Journal'Global Xeloda Tablet Market' Report presents a professional and deep analysis on the present state of Xeloda Tablet Market 2017
Puma Biotechnology lines up participants for Phase III breast cancer test - Patient Daily: Patient DailyPuma Biotechnology lines up participants for Phase III breast cancer testPatient DailyThose who will take part in the study will take either PB272 and Xeloda or Tykerb and Xeloda
Drug Xeloda prolongs survival for some breast cancer patients ... - Chicago Tribune: Chicago TribuneDrug Xeloda prolongs survival for some breast cancer patients

	Bookmark this site

	Subscribe to the News